Becker's Healthcare November 10, 2021
Hannah Mitchell

The COVID-19 pandemic has accelerated the adoption of digital health for about 20 months, but the FDA’s health IT agenda has remained largely untouched, Politico reported Nov. 10.

Five things to know:

  1. The FDA is facing several questions on the future of medical software and how this technology plays a role in telehealth and clinical decision-making moving forward, Politico reported.
  2. At the start of the pandemic, the FDA relaxed regulations on products that helped deliver virtual care. Yet once the public health emergency comes to an end, there isn’t a clear path as to what happens with these technologies, according to the report.
  3. The health IT industry is also looking for signs from the FDA on how it will regulate clinical...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: Digital Health, FDA, Govt Agencies, Health IT, Technology
Big Health’s Softbank Money, FDA Board Member Send Strong Signals About Digital Therapeutics Market
Will FDA and DOJ Reassert Their Enforcement Muscle With Life Sciences in 2022?
Neurological devices, diagnostics dominate latest FDA breakthrough designations
5 questions facing the FDA in 2022
Major Challenges Lie Ahead for FDA and Biopharma